COVID-19

COVID antiviral uptake low among eligible Americans Over the course of the study, most participants were eligible for antiviral use. CIDRAP

A new report published in Open Forum Infectious Diseases demonstrates that, despite the proven effectiveness of Paxlovid and molnupiravir against severe COVID-19 outcomes, uptake of these two antivirals remains low among Americans with COVID.

...

Respiratory virus levels climb as JN.1 dominates COVID detections PeopleImages/iStock CIDRAP

... In its tracking of three main viruses that drive visits to health providers for symptoms such as fever and sore throat, the CDC said respiratory syncytial virus (RSV) activity remains elevated, especially for young children. Meanwhile, COVID-19 activity is increasing in many parts of the country, as is seasonal flu, though hospital bed occupancy and intensive care unit (ICU) capacity for all patients remains stable.

...

..

COVID map shows where cases are highest across US Four states showed the highest rate of positive tests in the country in the week ended December 16. Newsweek

...

In only four states in the entire country the rate was above 15 percent. Region Seven, which includes Iowa, Kansas, Missouri and Nebraska, had the highest rate in the country as of the week ending on December 16, 18.5 percent. For weeks the four states have been identified as the worst-hit by the virus in the country, with more people testing positive than anywhere else.